The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › fagfællebedømt
Exogenous Glucagon-Like Peptide-2 (GLP-2) treatment improves intestinal wet weight absorption in short bowel syndrome (SBS) patients. In healthy subjects, administration of GLP-2 increases small intestinal blood flow. The aim of the study was to evaluate the effect of GLP-2 on mesenteric blood flow and dynamic changes in cardiac parameters in SBS patients with jejunostomy and varying length of remnant small intestine.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Regulatory Peptides |
Vol/bind | 168 |
Udgave nummer | 1-3 |
Sider (fra-til) | 32-8 |
Antal sider | 7 |
ISSN | 0167-0115 |
DOI | |
Status | Udgivet - 2011 |
ID: 34043197